HealthQuill Pharma
Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to a statement from the University of Adelaide.
Drugs Health Pharma

A new oral drug may stop triple-negative breast cancer in its tracks

HQ Team February 8, 2024: Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to.

Read More
Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US regulatory body placed the experiments on full clinical hold, according to a company statement.
Drugs Health Pharma

Gilead Sciences puts last-stage blood cancer trials on hold after FDA order

HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Medical Pharma

‘Pharma firms manipulate patents to curb competition and drive prices’

A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent.

Read More
Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss firm access to a key drug for treating blood cancer.
Drugs Health Pharma

Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio

HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss.

Read More
Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5 billion plant in Germany to make devices for treating diabetes and obesity.
Drugs Health Pharma

Novo Nordisk buys 3 Catalent sites for $11bn to meet rising demand for Wegovy

HQ Team February 5, 2024: Novo Nordisk will acquire three manufacturing sites in an $11bn deal to expand its production of weightless drugs.

Read More
Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease between January-October 2023 period, according to the WHO.
Drugs Health Pharma

Measles spreading rapidly across Europe, WHO calls for urgent curbs

HQ Team February 4, 2024: Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease.

Read More
A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to a study by the US National Institutes of Health.
Health Medical Pharma

CBT treatment may aid anxiety disorders in children: NIH study

HQ Team February 3, 2024: A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to.

Read More
Climate Health Pharma

Urban farms offer promise in reducing carbon footprints with sustainable strategies

Bharti Jayshankar February 2, 2024: As urban farming gains momentum as a solution to environmental and health challenges, a recent international collaboration delves.

Read More
Drugs Medical Pharma

Promising new treatment on the horizon for ALS

HQ Team February 1, 2024: Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease is a rare neurodegenerative disorder affecting both upper.

Read More
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed to rope in a partner to cut costs of obtaining standard regulatory approval.
Drugs Health Pharma

Biogen abandons Alzheimer’s drug Aduhelm to focus on Leqembi

Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed.

Read More